Eli Lilly To Stop Producing Humulin®50/50 Insulin

Aug 10, 2009
6,866 views

After careful consideration, Eli Lilly and Company has decided to stop producing Humulin® 50/50. Use of this insulin has been declining and it is estimated that about 3000 patients nationwide will be impacted by this discontinuation. The insulin Humalog 50/50 is still available.

Lilly’s first priority is to assist patients in transitioning as smoothly as possible to an alternate insulin therapy. Lilly is notifying HCPs regarding the timing for the discontinuation to allow affected patients sufficient time to transfer to alternate insulin formulations or treatments.

Based on current patient demand and our current stock of Humulin 50/50, Lilly anticipates this insulin formulation should be available at pharmacies until the end of April 2010. All vials of Humulin 50/50 shipped before that date will now have the following notice printed on the carton, “Humulin 50/50 is being discontinued. Contact your physician to change to another insulin. For information, call 1-800-545-5979.”

To assist in communicating information concerning this product discontinuation to patients who currently use Humulin 50/50, we have the patient information for you to give to your patients. The sheet will inform patients about the discontinuation and provide answers to questions they might have. To avoid confusion, please be sure to distribute the sheet only to patients currently using Humulin 50/50.

For additional information, Patient Information Sheet